drugset

drugset / Trial / NCT07171983

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

NCT07171983 ↗

Phase 1 Recruiting 46 enrolled Bristol-Myers Squibb

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-986454 in participants with Rheumatoid Arthritis

Timeline

Start: 2026-02-27
Primary completion: 2027-06-28
Completion: 2027-08-25

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	BMS-986454	Unknown	—	—

Indications